Nifty
:
14310.80
Sensex
:
47883.38
-524.05 (-3.53%)
-1707.94 (-3.44%)
Nifty
Sensex
:
:
14310.80
47883.38
-524.05 (-3.53%)
-1707.94 (-3.44%)

Laurus Labs Ltd.

Pharmaceuticals & Drugs - API

Rating :
64/99

BSE: 540222 | NSE: LAURUSLABS

NSE BSE
416.50
12-Apr-2021
  • Open
  • High
  • Low
  • Previous Close
  •  417.40
  •  437.90
  •  405.00
  •  421.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  7673237
  •  32470.81
  •  437.90
  •  78.11

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 22,333.39
  • 28.02
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 23,388.53
  • 0.12%
  • 9.08

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.45%
  • 9.88%
  • 34.17%
  • FII
  • DII
  • Others
  • 20.68%
  • 3.16%
  • 4.66%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 9.76
  • 11.26

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 9.28
  • 6.43

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 13.73
  • 15.05

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 30.89
  • 30.98

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 4.10
  • 4.01

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 14.39
  • 13.85

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
1,288.42
729.59
76.60%
1,138.84
712.42
59.86%
974.32
550.57
76.97%
839.14
635.16
32.11%
Expenses
862.12
581.42
48.28%
764.97
574.61
33.13%
696.00
467.31
48.94%
647.37
523.17
23.74%
EBITDA
426.30
148.17
187.71%
373.87
137.81
171.29%
278.32
83.26
234.28%
191.77
111.99
71.24%
EBIDTM
33.09%
20.31%
32.83%
19.34%
28.57%
15.12%
22.85%
17.63%
Other Income
6.93
1.92
260.94%
5.12
1.36
276.47%
7.09
4.50
57.56%
1.68
1.62
3.70%
Interest
17.43
20.83
-16.32%
13.68
25.57
-46.50%
15.14
22.53
-32.80%
20.66
17.57
17.59%
Depreciation
51.64
47.55
8.60%
51.00
47.83
6.63%
48.80
45.84
6.46%
46.05
43.47
5.94%
PBT
364.16
81.71
345.67%
314.31
65.77
377.89%
221.47
19.39
1,042.19%
126.74
52.57
141.09%
Tax
91.31
8.24
1,008.13%
72.04
9.22
681.34%
49.69
4.29
1,058.28%
16.59
9.39
76.68%
PAT
272.85
73.47
271.38%
242.27
56.55
328.42%
171.78
15.10
1,037.62%
110.15
43.18
155.09%
PATM
21.18%
10.07%
21.27%
7.94%
17.63%
2.74%
13.13%
6.80%
EPS
5.08
1.37
270.80%
4.52
1.06
326.42%
3.21
0.28
1,046.43%
2.06
0.81
154.32%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
4,240.72
2,831.72
2,291.92
2,056.17
1,904.65
1,777.58
1,326.59
1,159.72
Net Sales Growth
61.38%
23.55%
11.47%
7.96%
7.15%
34.00%
14.39%
 
Cost Of Goods Sold
1,948.73
1,382.89
1,224.80
1,056.02
989.29
1,000.15
821.27
720.43
Gross Profit
2,291.99
1,448.84
1,067.12
1,000.15
915.36
777.43
505.32
439.29
GP Margin
54.05%
51.16%
46.56%
48.64%
48.06%
43.74%
38.09%
37.88%
Total Expenditure
2,970.46
2,267.17
1,935.93
1,642.85
1,497.01
1,415.38
1,131.46
956.09
Power & Fuel Cost
-
136.77
109.37
94.21
66.27
57.95
49.86
35.03
% Of Sales
-
4.83%
4.77%
4.58%
3.48%
3.26%
3.76%
3.02%
Employee Cost
-
320.77
276.33
238.14
204.73
175.46
131.38
103.25
% Of Sales
-
11.33%
12.06%
11.58%
10.75%
9.87%
9.90%
8.90%
Manufacturing Exp.
-
239.50
178.96
150.78
139.47
106.97
80.61
47.96
% Of Sales
-
8.46%
7.81%
7.33%
7.32%
6.02%
6.08%
4.14%
General & Admin Exp.
-
114.23
97.48
73.17
65.42
49.09
28.39
27.30
% Of Sales
-
4.03%
4.25%
3.56%
3.43%
2.76%
2.14%
2.35%
Selling & Distn. Exp.
-
61.53
31.96
24.09
22.65
16.49
12.46
12.54
% Of Sales
-
2.17%
1.39%
1.17%
1.19%
0.93%
0.94%
1.08%
Miscellaneous Exp.
-
11.49
17.03
6.44
9.18
9.27
7.49
9.58
% Of Sales
-
0.41%
0.74%
0.31%
0.48%
0.52%
0.56%
0.83%
EBITDA
1,270.26
564.55
355.99
413.32
407.64
362.20
195.13
203.63
EBITDA Margin
29.95%
19.94%
15.53%
20.10%
21.40%
20.38%
14.71%
17.56%
Other Income
20.82
5.92
16.15
29.19
33.44
4.36
34.07
8.82
Interest
66.91
89.59
88.19
79.64
99.90
111.11
101.11
58.71
Depreciation
197.49
187.27
164.19
125.45
105.98
86.41
61.53
32.88
PBT
1,026.68
293.61
119.75
237.42
235.19
169.04
66.57
120.86
Tax
229.63
38.34
25.99
69.81
43.86
34.90
-1.55
23.64
Tax Rate
22.37%
13.06%
21.70%
29.40%
18.65%
20.65%
-2.33%
19.56%
PAT
797.05
255.27
93.76
167.61
191.33
134.14
68.12
97.22
PAT before Minority Interest
797.05
255.27
93.76
167.61
191.33
134.14
68.12
97.22
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
18.80%
9.01%
4.09%
8.15%
10.05%
7.55%
5.13%
8.38%
PAT Growth
323.29%
172.26%
-44.06%
-12.40%
42.63%
96.92%
-29.93%
 
EPS
14.85
4.76
1.75
3.12
3.57
2.50
1.27
1.81

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
1,769.78
1,558.41
1,482.64
1,330.45
856.80
722.10
358.42
Share Capital
106.91
106.44
106.03
105.76
82.38
82.13
77.84
Total Reserves
1,658.24
1,446.60
1,370.75
1,218.84
771.47
637.03
277.22
Non-Current Liabilities
214.24
295.49
174.30
132.34
428.11
363.73
203.92
Secured Loans
165.02
258.71
141.66
124.56
353.61
303.68
188.17
Unsecured Loans
0.00
0.00
0.00
0.00
106.13
0.00
0.00
Long Term Provisions
45.85
30.05
20.84
14.59
6.77
5.13
3.93
Current Liabilities
1,692.37
1,423.90
1,306.89
1,120.75
883.75
802.49
710.87
Trade Payables
615.61
488.31
312.33
263.10
247.61
230.81
227.47
Other Current Liabilities
261.47
244.50
231.26
199.11
141.05
133.34
164.25
Short Term Borrowings
790.51
684.21
758.52
644.17
481.42
431.63
312.18
Short Term Provisions
24.77
6.89
4.78
14.37
13.66
6.70
6.97
Total Liabilities
3,676.39
3,277.80
2,963.83
2,583.54
2,168.66
1,888.32
1,273.21
Net Block
1,726.34
1,629.07
1,480.80
1,229.93
1,021.03
801.01
499.27
Gross Block
2,385.73
2,105.42
1,793.75
1,418.58
1,106.33
986.17
623.32
Accumulated Depreciation
659.39
476.35
312.95
188.65
85.30
185.16
124.04
Non Current Assets
1,864.33
1,814.84
1,716.23
1,443.71
1,165.92
1,024.41
696.70
Capital Work in Progress
67.18
109.63
163.18
143.26
69.60
109.67
116.10
Non Current Investment
3.40
3.40
3.40
3.40
7.04
7.45
0.00
Long Term Loans & Adv.
40.80
25.58
29.36
25.95
29.22
93.94
68.50
Other Non Current Assets
26.61
47.16
39.50
41.17
39.03
12.34
12.82
Current Assets
1,812.06
1,462.96
1,247.59
1,139.82
1,002.73
862.27
574.81
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
905.22
681.94
584.78
509.05
487.09
475.50
328.10
Sundry Debtors
791.42
709.94
570.59
567.61
444.86
285.07
194.88
Cash & Bank
1.74
3.02
3.06
4.09
28.77
58.88
23.20
Other Current Assets
113.68
32.84
30.53
34.07
42.00
42.82
28.64
Short Term Loans & Adv.
61.91
35.22
58.63
25.01
23.86
22.75
19.80
Net Current Assets
119.69
39.05
-59.30
19.07
118.98
59.78
-136.06
Total Assets
3,676.39
3,277.80
2,963.82
2,583.53
2,168.65
1,888.32
1,273.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
347.41
297.66
342.49
331.99
181.97
-64.71
121.23
PBT
293.61
119.75
237.42
235.19
169.04
66.57
120.86
Adjustment
293.21
247.69
216.47
199.38
200.57
136.26
83.06
Changes in Working Capital
-199.76
-44.46
-49.48
-52.45
-154.37
-250.72
-59.27
Cash after chg. in Working capital
387.06
322.99
404.41
382.12
215.23
-47.89
144.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-39.64
-25.32
-61.91
-50.13
-33.26
-16.82
-23.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-221.12
-252.88
-384.15
-288.67
-312.20
-396.95
-311.82
Net Fixed Assets
-234.28
-254.84
-394.43
-354.15
-76.75
-353.86
Net Investments
0.00
-6.57
-1.22
-24.40
-7.01
-18.65
Others
13.16
8.53
11.50
89.88
-228.44
-24.44
Cash from Financing Activity
-127.66
-44.77
42.24
-53.61
103.32
486.08
203.03
Net Cash Inflow / Outflow
-1.37
0.02
0.59
-10.30
-26.91
24.42
12.44
Opening Cash & Equivalents
2.97
3.00
2.42
12.81
39.53
15.11
2.67
Closing Cash & Equivalent
1.69
2.97
3.00
2.42
12.81
39.53
15.11

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
33.02
29.18
139.28
125.25
499.30
419.61
189.14
ROA
7.34%
3.00%
6.04%
8.05%
6.61%
4.31%
7.64%
ROE
15.39%
6.19%
11.97%
18.12%
18.65%
14.47%
33.42%
ROCE
14.14%
8.22%
13.68%
16.52%
16.35%
13.74%
19.96%
Fixed Asset Turnover
1.26
1.18
1.29
1.53
1.73
1.66
1.87
Receivable days
96.76
101.97
100.40
95.66
73.56
65.47
61.02
Inventory Days
102.29
100.87
96.48
94.12
97.00
109.61
102.73
Payable days
80.46
72.80
61.13
59.14
58.52
69.29
86.77
Cash Conversion Cycle
118.59
130.03
135.75
130.64
112.05
105.79
76.98
Total Debt/Equity
0.60
0.67
0.66
0.64
1.20
1.14
1.54
Interest Cover
4.28
2.36
3.98
3.35
2.52
1.66
3.06

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013

News Update:


  • Laurus Labs wins coveted Golden Peacock Award for excellence in corporate governance
    11th Feb 2021, 10:23 AM

    This is the first year that the company has won this coveted award

    Read More
  • Laurus Labs acquires 72.55% stake in Richcore Lifesciences
    21st Jan 2021, 09:00 AM

    With this transaction Richcore Lifesciences has become a subsidiary company of Laurus Labs

    Read More
  • Laurus Labs’ arm incorporates wholly-owned subsidiary
    12th Jan 2021, 09:02 AM

    The said incorporation is for undertaking ingredients business and also for setting up Greenfield projects for new synthesis business

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.